FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307372016> ?p ?o ?g. }

• W4307372016 abstract "Background Virological failure remains a public health concern among patients with human immunodeficiency virus (HIV) after treatment initiation. Ethiopia is one of the countries that aims to achieve the global target of 90-90-90 that aims to achieve 90% virological suppression, but there is a paucity of evidence on the determinants of virological failure. Therefore, the study is intended to assess determinants of virological treatment failure among patients on first-line highly active antiretroviral therapy (HAART) at Mizan Tepi University Teaching Hospital (MTUTH), Southwest Ethiopia. Method A hospital-based unmatched case-control study was conducted from 11 November to 23 December 2020, among 146 cases and 146 controls. All cases and controls were selected randomly using computer-generated random numbers based on their medical record numbers. During the document review, data were collected using checklists, entered into Epi-data version 4.0.2, and analyzed by SPSS version 25. A multivariable logistic regression analysis was done to identify the independent determinants of virological treatment failure. Results In this study, being male (adjusted odds ratio (AOR) = 1.89, 95% CI: 1.04, 3.47), substance use (AOR = 2.67, 95% CI: 1.40, 4.95), baseline hemoglobin (Hgb) &lt; 12 mg/dl (AOR = 3.22, 95% CI: 1.82, 5.99), poor drug adherence (AOR = 3.84, 95% CI: 1.77, 5.95), restart ART medication (AOR = 2.45, 95% CI: 1.69, 7.35), and opportunistic infection (OI) while on HAART (AOR = 4.73, 95% CI: 1.76, 12.11) were determinants of virological treatment failure. Conclusion The study revealed that the sex of the patient, history of substance use, baseline Hgb &lt; 12 mg/dl, poor drug adherence, restart after an interruption, and having OI through the follow-up period were determinants of virological failure. Therefore, program implementation should consider gender disparity while men are more prone to virological failure. It is also imperative to implement targeted interventions to improve drug adherence and interruption problems in follow-up care. Moreover, patients with opportunistic infections and restart HAART need special care and attention." @default.
• W4307372016 created "2022-11-01" @default.
• W4307372016 creator A5000199132 @default.
• W4307372016 creator A5003194139 @default.
• W4307372016 creator A5010819335 @default.
• W4307372016 creator A5020514337 @default.
• W4307372016 creator A5037551425 @default.
• W4307372016 creator A5041058795 @default.
• W4307372016 creator A5067958149 @default.
• W4307372016 creator A5069441588 @default.
• W4307372016 creator A5085617780 @default.
• W4307372016 date "2022-10-25" @default.
• W4307372016 modified "2023-09-30" @default.
• W4307372016 title "Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: A case-control study" @default.
• W4307372016 cites W1593991998 @default.
• W4307372016 cites W1952524289 @default.
• W4307372016 cites W1976481753 @default.
• W4307372016 cites W1989878476 @default.
• W4307372016 cites W2011461862 @default.
• W4307372016 cites W2047783717 @default.
• W4307372016 cites W2048446450 @default.
• W4307372016 cites W2054105428 @default.
• W4307372016 cites W2055983710 @default.
• W4307372016 cites W2086377567 @default.
• W4307372016 cites W2130516277 @default.
• W4307372016 cites W2139384600 @default.
• W4307372016 cites W2146592048 @default.
• W4307372016 cites W2323659380 @default.
• W4307372016 cites W2342777015 @default.
• W4307372016 cites W2343783954 @default.
• W4307372016 cites W2591612004 @default.
• W4307372016 cites W2605163208 @default.
• W4307372016 cites W2610466423 @default.
• W4307372016 cites W2738155037 @default.
• W4307372016 cites W2742226023 @default.
• W4307372016 cites W2790465384 @default.
• W4307372016 cites W2942818208 @default.
• W4307372016 cites W2961146937 @default.
• W4307372016 cites W2977677900 @default.
• W4307372016 cites W2981964218 @default.
• W4307372016 cites W2997152936 @default.
• W4307372016 cites W3002295907 @default.
• W4307372016 cites W3044084116 @default.
• W4307372016 cites W3048527112 @default.
• W4307372016 cites W3105057655 @default.
• W4307372016 cites W3112789710 @default.
• W4307372016 cites W3121344925 @default.
• W4307372016 doi "https://doi.org/10.3389/fpubh.2022.916454" @default.
• W4307372016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36408009" @default.
• W4307372016 hasPublicationYear "2022" @default.
• W4307372016 type Work @default.
• W4307372016 citedByCount "1" @default.
• W4307372016 countsByYear W43073720162023 @default.
• W4307372016 crossrefType "journal-article" @default.
• W4307372016 hasAuthorship W4307372016A5000199132 @default.
• W4307372016 hasAuthorship W4307372016A5003194139 @default.
• W4307372016 hasAuthorship W4307372016A5010819335 @default.
• W4307372016 hasAuthorship W4307372016A5020514337 @default.
• W4307372016 hasAuthorship W4307372016A5037551425 @default.
• W4307372016 hasAuthorship W4307372016A5041058795 @default.
• W4307372016 hasAuthorship W4307372016A5067958149 @default.
• W4307372016 hasAuthorship W4307372016A5069441588 @default.
• W4307372016 hasAuthorship W4307372016A5085617780 @default.
• W4307372016 hasBestOaLocation W43073720161 @default.
• W4307372016 hasConcept C126322002 @default.
• W4307372016 hasConcept C142462285 @default.
• W4307372016 hasConcept C146304588 @default.
• W4307372016 hasConcept C151956035 @default.
• W4307372016 hasConcept C156957248 @default.
• W4307372016 hasConcept C187212893 @default.
• W4307372016 hasConcept C203014093 @default.
• W4307372016 hasConcept C2993143319 @default.
• W4307372016 hasConcept C3013748606 @default.
• W4307372016 hasConcept C44249647 @default.
• W4307372016 hasConcept C71924100 @default.
• W4307372016 hasConceptScore W4307372016C126322002 @default.
• W4307372016 hasConceptScore W4307372016C142462285 @default.
• W4307372016 hasConceptScore W4307372016C146304588 @default.
• W4307372016 hasConceptScore W4307372016C151956035 @default.
• W4307372016 hasConceptScore W4307372016C156957248 @default.
• W4307372016 hasConceptScore W4307372016C187212893 @default.
• W4307372016 hasConceptScore W4307372016C203014093 @default.
• W4307372016 hasConceptScore W4307372016C2993143319 @default.
• W4307372016 hasConceptScore W4307372016C3013748606 @default.
• W4307372016 hasConceptScore W4307372016C44249647 @default.
• W4307372016 hasConceptScore W4307372016C71924100 @default.
• W4307372016 hasLocation W43073720161 @default.
• W4307372016 hasLocation W43073720162 @default.
• W4307372016 hasLocation W43073720163 @default.
• W4307372016 hasLocation W43073720164 @default.
• W4307372016 hasOpenAccess W4307372016 @default.
• W4307372016 hasPrimaryLocation W43073720161 @default.
• W4307372016 hasRelatedWork W2037611947 @default.
• W4307372016 hasRelatedWork W2138334887 @default.
• W4307372016 hasRelatedWork W2218945907 @default.
• W4307372016 hasRelatedWork W2335988042 @default.
• W4307372016 hasRelatedWork W2583387738 @default.
• W4307372016 hasRelatedWork W2772777539 @default.
• W4307372016 hasRelatedWork W2971695752 @default.
• W4307372016 hasRelatedWork W3010075638 @default.

• next